Similar articles

• Immunoglobulin G4-related prostatitis: a case-control study focusing on clinical and pathologic characteristics.

  Buijs J, Maillette de Buy Wenniger L, van Leenders G, Verheij J, van Onna I, Hansen B, van Heerde M, Krak N, Beuers U, Bruno M, van Buuren H. Buijs J, et al. Urology. 2014 Mar;83(3):521-6. doi: 10.1016/j.urology.2013.10.052. Urology. 2014. PMID: 24581512
• Pathogenic consequences in semen quality of an autoimmune response against the prostate gland: from animal models to human disease.

  Motrich RD, Maccioni M, Ponce AA, Gatti GA, Oberti JP, Rivero VE. Motrich RD, et al. J Immunol. 2006 Jul 15;177(2):957-67. doi: 10.4049/jimmunol.177.2.957. J Immunol. 2006. PMID: 16818751
• [Morphological and molecular biological peculiarities of the experimental autoimmune prostatitis rat model].

  Zhou XH, Han L, Zhou ZH, Liu ZD, Yang JX, Lv YW, You CL. Zhou XH, et al. Zhonghua Nan Ke Xue. 2005 Apr;11(4):290-5. Zhonghua Nan Ke Xue. 2005. PMID: 15921263 Chinese.
• Autoimmune prostatitis: state of the art.

  Motrich RD, Maccioni M, Riera CM, Rivero VE. Motrich RD, et al. Scand J Immunol. 2007 Aug-Sep;66(2-3):217-27. doi: 10.1111/j.1365-3083.2007.01971.x. Scand J Immunol. 2007. PMID: 17635799 Review.
• [The use of vitaprost in the treatment of patients with prostate diseases].

  Demidko IuL, Gazimiev MA, Baĭduvaliev AM, Lachinov ÉL, Saenko VS. Demidko IuL, et al. Urologiia. 2014 Jan-Feb;(1):62-4, 66-7. Urologiia. 2014. PMID: 24772777 Review. Russian.